# Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

> **NCT05227677** · NA · COMPLETED · sponsor: **Asahi Kasei Therapeutics Corporation** · enrollment: 200 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** GA guided anti-diabetic therapy adjustment
- **OTHER:** current guidelines to adjust treatment

## Key facts

- **NCT ID:** NCT05227677
- **Lead sponsor:** Asahi Kasei Therapeutics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-15
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227677, "Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05227677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*